Sign up to save your podcasts
Or
Share Assessing the safety of microbiome perturbations
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Assessing the safety of microbiome perturbations
This article "Assessing the safety of microbiome perturbations" is published in Microbial Genomics.
Author:Aline Metris
Journal:Microbial Genomics
Year:2025
Podcast type:Short
The authors are
Affiliations:
Unilever, Safety, Environmental and Regulatory Sciences (SERS), Sharnbrook, UK; 2 Microbiome, Food Innovation and Food Security Theme, Rowett Institute, University of Aberdeen, Aberdeen, UK; 3 BugBiome, Cambridge, UK; 4 Atlantia Clinical Trials, Cork, Ireland; 5 Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; 6 Unilever R&D Port Sunlight, Bebington, Wirral, UK; 7 Division of Dermatology and Musculoskeletal Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; 8 Ulster University, Coleraine, NI BT52 1SA, Ireland; 9 Department of Microbes, Infection and Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK; 10Reckitt, Slough, UK; 11University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, OH, USA; 12School of Biosciences, Sir Martin Evans Building, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK; 13School of Microbiology, University College Cork, Cork, Ireland; 14APC Microbiome Ireland, University College, Cork, Ireland; 15The Procter & Gamble Company, Mason, OH, USA; 16Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK; 17Department of Computing, University of Turku, Turku FI-20014, Finland; 18School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; 19Health & Biosciences, IFF, c/o Danisco UK Ltd., Reigate RH2 9PW, UK; 20European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, UK; 21Food, Microbiomes and Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK; 22Division of Digestive Diseases, Imperial College London, London, UK; 23NIHR Imperial BRC Organoid Facility, Imperial College London, London, UK.
View all episodes
By ReSayPodcastThis article "Assessing the safety of microbiome perturbations" is published in Microbial Genomics.
Author:Aline Metris
Journal:Microbial Genomics
Year:2025
Podcast type:Short
The authors are
Affiliations:
Unilever, Safety, Environmental and Regulatory Sciences (SERS), Sharnbrook, UK; 2 Microbiome, Food Innovation and Food Security Theme, Rowett Institute, University of Aberdeen, Aberdeen, UK; 3 BugBiome, Cambridge, UK; 4 Atlantia Clinical Trials, Cork, Ireland; 5 Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; 6 Unilever R&D Port Sunlight, Bebington, Wirral, UK; 7 Division of Dermatology and Musculoskeletal Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; 8 Ulster University, Coleraine, NI BT52 1SA, Ireland; 9 Department of Microbes, Infection and Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK; 10Reckitt, Slough, UK; 11University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, OH, USA; 12School of Biosciences, Sir Martin Evans Building, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK; 13School of Microbiology, University College Cork, Cork, Ireland; 14APC Microbiome Ireland, University College, Cork, Ireland; 15The Procter & Gamble Company, Mason, OH, USA; 16Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK; 17Department of Computing, University of Turku, Turku FI-20014, Finland; 18School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; 19Health & Biosciences, IFF, c/o Danisco UK Ltd., Reigate RH2 9PW, UK; 20European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, UK; 21Food, Microbiomes and Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK; 22Division of Digestive Diseases, Imperial College London, London, UK; 23NIHR Imperial BRC Organoid Facility, Imperial College London, London, UK.